• Nurix Therapeutics Chief Legal Officer Christine Ring sold 11,008 shares on July 2, 2026 at USD 23.56.
• Ring exercised stock options for 11,008 shares at USD 1.86 and USD 8.72.
• She held 13,579 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001817199-26-000024), on July 02, 2026, and is solely responsible for the information contained therein.